Characteristics | 5-DFS (%) | Univariate P value | HR | Multivariate P value |
---|---|---|---|---|
Sex | 0.266 | |||
Male | 54.2 | |||
Female | 0 | |||
Age | 0.596 | |||
<60 | 33.3 | |||
≥60 | 56.3 | |||
Differentiation | 0.932 | |||
Differentiated | 50.0 | |||
Undifferentiated | 41.7 | |||
Primary tumor size | 0.731 | |||
<3 cm | 33.3 | |||
≥3 cm | 50.3 | |||
Lymphatic invasion | 0.731 | |||
LI (−) | 33.3 | |||
LI (+) | 50.3 | |||
Vascular invasion | 0.049 | 0.061 | ||
VI (−) | 30.3 | Ref 0.128 | ||
VI (+) | 80.0 | |||
Perineural invasion | 0.858 | |||
PI (−) | 50.5 | |||
PI (+) | 40.0 | |||
T stage | 0.297 | |||
T1-2 | 33.3 | |||
T3-4 | 55.6 | |||
N stage | 0.761 | |||
N0 | 50.0 | |||
N1-3 | 46.4 | |||
AJCC 7th stage | 0.227 | |||
Stage 1–2 | 28.6 | |||
Stage 3-4 | 63.5 | |||
Number of metastatic Tumor | 0.059 | |||
Single | 30.3 | |||
Multiple | 80.0 | |||
Size of metastatic Tumor | 0.702 | |||
<3 cm | 40.0 | |||
≥3 cm | 62.5 | |||
Lobar distribution | 0.683 | |||
Unilobar | 46.4 | |||
Bilobar | 50.0 | |||
Type of treatment | 0.073 | 0.072 | ||
Hepatic resecction | 80.0 | Ref 7.171 | ||
RFA | 30.3 |